3 CELL SIGNALING
Cells respond to extracellular signals produced by other cells or by themselves. This mechanism, called cell signaling, allows cell-cell communication and is necessary for the functional regulation and integration of multicellular organisms. Our discussion in this chapter not only provides the basis for understanding normal cell function but serves also as an introduction to the role of abnormal cell signaling in human disease.
Cell signaling mechanisms
Five major types of cell-cell signaling are considered (Figure 3-1):
Box 3-A Paracrine cell signaling
Mechanisms of action of cell signaling molecules
Cell signaling molecules exert their action after binding to receptors expressed by their target cells. Target cells, in turn, can determine either a negative or positive feedback action to regulate the release of the targeting hormone (Figure 3-2).
Cell receptors can be expressed on the cell surface of the target cells. Some receptors are intracellular proteins in the cytosol or the nucleus of target cells. Intracellular receptors require that the signaling molecules diffuse across the plasma membrane (Figure 3-3).
Steroid hormones (Box 3-B) belong to this class of signaling molecules. Steroid hormones are synthesized from cholesterol and include testosterone, estrogen, progesterone, and corticosteroids.
Testosterone, estrogen, and progesterone are sex steroids and are produced by the gonads. Corticosteroids are produced by the cortex of the adrenal gland and include two major classes: glucocorticoids, which stimulate the production of glucose, and mineralocorticoids, which act on the kidneys to regulate water and salt balance.
Steroid receptors are members of the steroid receptor superfamily. They act as transcription factors through their DNA binding domains, which have transcription activation or repression functions. Steroid hormones and related molecules can therefore regulate gene expression.
In the androgen insensitivity syndrome (also known as the testicular feminization syndrome [Tfm]), there is a mutation in the gene expressing the testosterone receptor such that the receptor cannot bind the hormone, and hence the cells do not respond to the hormone. Although genetically male, the individual develops the secondary sexual characteristics of a female. We discuss the androgen insensitivity syndrome in Chapter 21, Sperm Transport and Maturation.
Nitric oxide
Cell signaling molecules bind to cell surface receptors
A large variety of signaling molecules bind to cell surface receptors. Several groups are recognized
Pathways of intracellular signaling by cell surface receptors
Binding of a ligand (a growth factor) to the extracellular domain of these receptors induces receptor dimerization that results in receptor autophosphorylation (the two polypeptide chains phosphorylate one another). The autophosphorylation of the receptors determines the binding of the tyrosine kinase domain to downstream signaling molecules. Downstream signaling molecules bind to phosphotyrosine residues through domains called SH2 domains (for Src homology 2). Src (for sarcoma) is a gene present in the tumor-producing Rous sarcoma virus and encodes a protein that functions as a protein tyrosine kinase.
Clinical significance: Tyrosine kinases, targets for therapeutic agents
There are two main classes of tyrosine kinases: (1) receptor tyrosine kinases are transmembrane proteins with a ligand-binding extracellular domain and a catalyic intracellular kinase domain (see Figure 3-5), and (2) nonreceptor tyrosine kinases found in the cytosol, nucleus, and inner side of the plasma membrane.
In the absence of a ligand, receptor tyrosine kinases are unphosphorylated and monomeric. The nonreceptor tyrosine kinase is maintained in an inactive state by cellular inhibitor proteins. Activation occurs when the inhibitors are dissociated or by recruitment to transmembrane receptors that trigger autophosphorylation. Tyrosine kinase activity terminates when tyrosine phosphatases hydrolyze tyrosyl phosphates and by induction of inhibitory molecules.
The cAMP pathway
The intracellular signaling effects of cAMP (Figure 3-6) are mediated by the enzyme cAMP-dependent protein kinase (or protein kinase A). In its inactive form, protein kinase A is a tetramer composed of two regulatory subunits (to which cAMP binds) and two catalytic subunits. Binding of cAMP results in the dissociation of the catalytic subunits. Free catalytic subunits can phosphorylate serine residues on target proteins.